Status:
COMPLETED
Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab
Lead Sponsor:
ECOG-ACRIN Cancer Research Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Eligibility:
All Genders
18-120 years
Brief Summary
RATIONALE: DNA analysis of tumor tissue may help doctors predict how well patients will respond to treatment. PURPOSE: This research study is studying biomarkers in tissue samples from patients with ...
Detailed Description
OBJECTIVES: Primary * To demonstrate that vascular endothelial growth factor-A (VEGFA) haplotypes that are associated with an increased VEGFA expression will predict superior outcome for patients wi...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Enrolled on ECOG-E2100
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
April 5 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 8 2011
Estimated Enrollment :
363 Patients enrolled
Trial Details
Trial ID
NCT01156168
Start Date
April 5 2011
End Date
September 8 2011
Last Update
May 17 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.